Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Megprate 333mg/145mg Tablet

Prescription Icon
Prescription Required

Marketer

Ridhima Biocare

Salt Composition

Sodium Valproate (333mg) + Valproic Acid (145mg)

Overview Megprate 333mg/145mg Tablet

Epileptic seizures, characterized by recurring fits and abnormal brain activity, are effectively managed by the dual-action formulation of Lamictal XR 333mg/145mg tablets. This medication calms nerve function, thereby preventing seizure episodes. Administer this medication with food, following your physician's prescribed dosage, which may be gradually increased until your condition stabilizes. While therapeutic effects might not be immediately apparent (requiring several weeks), consistent use is crucial for optimal benefit. Discontinuation should only occur under your doctor's guidance, as abrupt cessation may trigger increased seizure frequency or exacerbate any existing bipolar disorder. Commonly reported side effects include nausea and tremors; less frequent occurrences include vomiting, headache, hepatic complications, and upper abdominal discomfort. Persistent or bothersome side effects warrant immediate medical attention; management strategies may be available to mitigate these issues. Prior to initiating treatment, inform your physician of any pre-existing conditions, including renal or hepatic impairment, meningitis, depression, or suicidal ideation. Comprehensive disclosure of all other medications is essential, including contraceptives, as interactions are possible. Use during pregnancy or breastfeeding requires careful consideration and potential dosage adjustments based on individual medical necessity. Refrain from operating machinery (e.g., vehicles, bicycles) if drowsiness or dizziness occur. Regular blood tests will monitor treatment efficacy. Alcohol consumption should be avoided, as it can potentiate side effects. Weight gain is a potential consequence; maintaining a healthy diet, limiting high-calorie snacks, and regular physical activity are recommended. Report any unusual mood alterations, worsening depression, or emergence/escalation of suicidal thoughts or behavior to your physician promptly.

Primary Ingredients of Megprate 333mg/145mg Tablet

No text provided to rephrase.

Uses of Megprate 333mg/145mg Tablet

Seizure disorder

Major Benefits of Megprate 333mg/145mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 333mg/145mg Megprate tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.

Common Side effects of Megprate 333mg/145mg Tablet:

  • Nausea
  • Tremors

How to use Megprate 333mg/145mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the 333mg/145mg Megprate tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Megprate 333mg/145mg Tablet works:

Each Megprate 333mg/145mg tablet contains a dual anticonvulsant formulation of sodium valproate and valproic acid.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Megprate 333mg/145mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Megprate 333mg/145mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in rare, life-threatening circumstances where the potential benefits outweigh the known hazards. Always seek medical advice before use.

Breast feedingBreast feedingSAFE IF PRESCRIBED

A 333mg/145mg Megprate tablet presents minimal breastfeeding risk. Research in humans indicates negligible drug transfer to breast milk, posing no apparent infant harm.

DrivingDrivingUNSAFE

Taking a Megprate 333mg/145mg tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

The use of Megprate 333mg/145mg Tablet in patients with kidney disease is likely safe. Current evidence indicates dose modification may not be necessary; however, a physician's consultation is advised. Individuals with pre-existing kidney conditions should discuss this medication with their doctor.

LiverLiverCAUTION

Patients with liver impairment should use Megprate 333mg/145mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Megprate 333mg/145mg tablets are contraindicated in individuals with severe or active liver disease.

What if you forget to take Megprate 333mg/145mg Tablet :

Should you forget a Megprate 333mg/145mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Megprate 333mg/145mg Tablet

LabelValue
Developing Good Habits No.
Treatment Category Neuroscience of the Central Nervous System

FAQs on Megprate 333mg/145mg Tablet

Drowsiness and sleepiness are possible side effects of Megprate 333mg/145mg Tablet. Refrain from activities requiring alertness, such as driving or operating machinery, until you know how this medication affects you. Report any drowsiness to your doctor.
Avoid alcohol while taking Megprate 333mg/145mg tablets; alcohol consumption intensifies its side effects.
Continue taking Megprate 333mg/145mg tablets as prescribed. Abruptly stopping the medication may worsen symptoms. Contact your doctor if you experience any problems while taking Megprate 333mg/145mg tablets.
Increasing your dosage beyond the recommended amount won't necessarily improve results; it could instead lead to serious side effects and toxicity. If your symptoms persist or worsen despite taking the recommended dose, seek medical advice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Megprate 333mg/145mg Tabl...
62
MRP 72
13% off